Innerskin is positioning itself at the forefront of the new generation of aesthetic medicine, firmly placing skin health at the center of its practices. Founded in 2022 and headquartered in France, Innerskin focuses on non-invasive technologies such as lasers, peelings, and injections, all customized by expert physicians to enhance individual beauty without transformation.
With a compelling slogan, "La médecine esthétique d’une nouvelle génération, qui place la santé de la peau au coeur de sa pratique," the company underlines its commitment to a transparent and health-centric approach to aesthetic care. This model is gaining traction in the burgeoning Health Care industry, where consumers seek personalized, effective, and less invasive options.
In December 2025, Innerskin secured a significant €13.00M in Early VC investment, backed by IRIS Ventures and Label Capital. This funding is a testament to investor confidence in Innerskin's innovative approach and market potential.